Sana's Smash IPO Tops Biotech Trio Raising $811M Combined
Gene therapy firm Sana Biotechnology Inc. priced an upsized initial public offering at a landmark valuation of $588 million, leading three biotechnology companies that went public Thursday after raising $811 million...To view the full article, register now.
Already a subscriber? Click here to view full article